U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188461188461Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedHas ResultsStage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the OropharynxDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00084682
188462188462Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerCompletedNo Results AvailableBreast Cancer|Hot Flashes|Sleep DisordersDrug: venlafaxine|Drug: zolpidem tartrate|Procedure: management of therapy complicationshttps://ClinicalTrials.gov/show/NCT00084669
188463188463Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV MelanomaCompletedNo Results AvailableIntraocular Melanoma|Melanoma (Skin)Biological: ipilimumab|Biological: Tyrosinase/gp100/MART-1 Peptideshttps://ClinicalTrials.gov/show/NCT00084656
188464188464GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsCompletedNo Results AvailableRecurrent Colon Cancer|Recurrent Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer|Unspecified Adult Solid Tumor, Protocol SpecificBiological: GTI-2040|Drug: oxaliplatin|Drug: capecitabine|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00084643
188465188465Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma ProtuberansCompletedNo Results AvailableAdult Fibrosarcoma|Dermatofibrosarcoma Protuberans|Recurrent Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue SarcomaDrug: imatinib mesylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00084630
188466188466Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction CarcinomaCompletedHas ResultsAdenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Gastric Cancer|Stage IIIA Gastric Cancer|Stage IIIB Gastric Cancer|Stage IIIC GastDrug: oxaliplatin|Drug: irinotecan hydrochloride|Drug: capecitabinehttps://ClinicalTrials.gov/show/NCT00084617
188467188467Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNo Results AvailableAdenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Gastric Cancer|Stage IIIA Gastric Cancer|Stage IIIB Gastric Cancer|Stage IIIC GastDrug: irinotecan hydrochloride|Biological: bevacizumab|Drug: cisplatin|Procedure: computed tomography|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00084604
188468188468Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNo Results AvailableColorectal CancerDrug: capecitabine|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00084591
188469188469Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNo Results AvailableBladder CancerDrug: celecoxib|Drug: rosiglitazone maleate|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00084578
188470188470Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate CancerWithdrawnNo Results AvailableProstate CancerDrug: estramustine phosphate sodium|Drug: paclitaxel|Drug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00084565
188471188471Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerActive, not recruitingNo Results AvailableProstate Cancer|Sexual Dysfunction|Sexuality and Reproductive IssuesRadiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00084552
188472188472Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast CancerActive, not recruitingNo Results AvailableBreast CancerRadiation: Radiation therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00084539
188473188473Computed Tomography (CT) Scans Using CT-On-Railsâ„¢ to Pinpoint the Location of the Tumor in Treating Patients With Prostate CancerCompletedNo Results AvailableProstate CancerProcedure: computed tomography|Procedure: ultrasound imaginghttps://ClinicalTrials.gov/show/NCT00084526
188474188474Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing CancerCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificBiological: trastuzumab|Drug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00084513
188475188475Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line ChemotherapyTerminatedHas ResultsExtensive Stage Small Cell Lung Cancer|Limited Stage Small Cell Lung Cancer|Recurrent Small Cell Lung CancerDrug: becatecarinhttps://ClinicalTrials.gov/show/NCT00084487
188476188476Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTerminatedNo Results AvailableGastrinoma|Glucagonoma|Insulinoma|Metastatic Gastrointestinal Carcinoid Tumor|Pancreatic Polypeptide Tumor|Pulmonary Carcinoid Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Recurrent Islet Cell Carcinoma|Regional Gastrointestinal Carcinoid Tumor|SomatoDrug: romidepsin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00084461
188477188477Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTerminatedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: celecoxib|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00084448
188478188478S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck CancerWithdrawnNo Results AvailableHead and Neck CancerDrug: cisplatin|Drug: docetaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00084435
188479188479N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk NeuroblastomaCompletedNo Results AvailableNeuroblastomaDrug: lestaurtinibhttps://ClinicalTrials.gov/show/NCT00084422
188480188480Iloprost in Preventing Lung Cancer in Patients at High Risk for This DiseaseCompletedHas ResultsLung Cancer|Precancerous ConditionDrug: iloprost|Other: placebohttps://ClinicalTrials.gov/show/NCT00084409
188481188481Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: letrozole|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00084396
188482188482Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the PancreasCompletedHas ResultsPancreatic CancerBiological: GVAX pancreatic cancer vaccinehttps://ClinicalTrials.gov/show/NCT00084383
188483188483Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic OophorectomyWithdrawnNo Results Availablebrca1 Mutation Carrier|brca2 Mutation Carrier|Ovarian CancerDrug: celecoxib|Procedure: oophorectomyhttps://ClinicalTrials.gov/show/NCT00084370
188484188484Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal WomenCompletedNo Results AvailableBreast CancerDrug: 4-hydroxytamoxifen|Procedure: breast imaging study|Procedure: radiomammographyhttps://ClinicalTrials.gov/show/NCT00084344
188485188485Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckActive, not recruitingNo Results AvailableHead and Neck CancerBiological: cetuximab|Drug: cisplatin|Drug: docetaxel|Procedure: adjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00084318
188486188486Procurement and Analysis of Specimens From Individuals With Pulmonary FibrosisRecruitingNo Results AvailablePulmonary Fibrosishttps://ClinicalTrials.gov/show/NCT00084305
188487188487Database for Stroke in Infants and ChildrenRecruitingNo Results AvailableCerebrovascular Accidenthttps://ClinicalTrials.gov/show/NCT00084292
188488188488CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)CompletedNo Results AvailableChronic Hepatitis CDrug: Consensus Interferon-Alpha, Interferon Gamma-1b, Ribavirinhttps://ClinicalTrials.gov/show/NCT00084279
188489188489Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedHas ResultsMethicillin Resistant Staphylococcus Aureus (MRSA)Drug: linezolid (Zyvox)|Drug: vancomycinhttps://ClinicalTrials.gov/show/NCT00084266
188490188490Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive PatientsCompletedNo Results AvailableHIV InfectionsDrug: Atazanavir/ Stavidine / Lamivudine|Drug: Atazanavir-Ritonavir/ Stavidine / Lamivudinehttps://ClinicalTrials.gov/show/NCT00084253

* Görseller ve İçerik tekif hakkına sahip olabilir